Skip to main content
. 2023 May 30;18(5):e0286364. doi: 10.1371/journal.pone.0286364

Table 1. Patient characteristics according to Her2/ATC treatment status.

AT NAT Total P Value
N = 62 (%) N = 54(%) N = 116 (%)
Age Mean (stdev) 61.6±11.3 68.2±10.4 64.6±11.3 0.001*
Group
<35 0(0.0) 0(0.0) 0(0.0) <0.001*
36–49 7(11.3) 3(5.5) 10(8.6)
50–64 27(43.5) 15(27.8) 42(36.2)
65+ 28(45.2) 36(66.7) 64(55.2)
BMI >30; Obesity 0.680
<30 39(62.9) 31(57.4) 70(60.3)
>30 23(37.1) 23(42.6) 46(39.7)
Ethnicity 1.000
White 51(82.3) 46(85.2) 97(83.6)
Black 8(12.9) 6(11.1) 14(12.1)
Hispanic 2(3.2) 2(3.7) 4(3.4)
Asian 1(1.6) 0(0.0) 1(0.9)
Other 0(0.0) 0(0.0) 0(0.0)
Comorbidities
HTN 27(43.5) 33(61.1) 60(51.3) 0.089
DM2 14(22.6) 10(18.5) 24(20.7) 0.752
Stroke/PE/DVT 9(14.5) 9(16.7) 18(15.5) 1.000
CAD 11(17.7) 17 (31.5) 28(24.1) 0.132
PAD 2(3.2) 3(5.6) 5(4.3) 0.888
Arrhythmia: a fib, a flutter 8(12.9) 14(25.9) 22(19.0) 0.122
Bradycardia 1(1.6) 6(11.1) 7(6.0) 0.080
Heart block/BBB 3(3.2) 5(9.3) 8(6.9) 0.572
Ventricular Arrhythmia 9(14.5) 4(7.4) 13(11.2) 0.359
Combination arrhythmias 2(3.2) 6(11.1) 8(6.9) 0.192
Family History of heart disease 20(32.3) 24(44.4) 44(37.9) 0.247
HF: Systolic 8(12.9) 4(7.4) 12(10.3) 0.507
HF: Diastolic 10(16.1) 20(37.0) 30(25.9) 0.019*
HF: both 10(16.1) 8(14.8) 18(15.5) 1.000
Valvular Disease 10(16.1) 15(27.8) 25(21.6) 0.195
pHTN 4(6.5) 4(7.4) 8(6.9) 0.863
HLD 26(41.9) 27(50.0) 53(45.7) 0.493
CKD/ESRD 2(3.2) 4(7.4) 6(5.2) 0.554
Smoking 0.210
Never Smoker 40(64.5) 25(46.3) 65(56.0)
Current Smoker 13(22.4) 17(31.5) 30(25.9)
Former Smoker 9(13.8) 12(22.2) 21(18.1)